|1.||Yeh, Hsin-Chih: 1 article (12/2015)|
|2.||Ke, Hung-Lung: 1 article (12/2015)|
|3.||Chai, Chee-Yin: 1 article (12/2015)|
|4.||Li, Ching-Chia: 1 article (12/2015)|
|5.||Huang, Chun-Nung: 1 article (12/2015)|
|6.||Li, Chien-Feng: 1 article (12/2015)|
|7.||Wu, Wen-Jeng: 1 article (12/2015)|
|8.||Chen, Wan Tzu: 1 article (12/2015)|
|9.||Li, Wei-Ming: 1 article (12/2015)|
|10.||Liang, Peir-In: 1 article (12/2015)|
12/01/2010 - "We also discuss questions of how these interactions are coordinated, and finally provide some perspective regarding Anillin's role in cancer."
10/01/2005 - "Thus, anillin is overexpressed in diverse common human tumors, but not simply as a consequence of being a proliferation marker. "
10/01/2005 - "Anillin mRNA expression was analyzed during tumor progression in breast, ovarian, kidney, colorectal, hepatic, lung, endometrial, and pancreatic tumors and in all tissues there was progressive increase in anillin mRNA expression from normal to benign to malignant to metastatic disease. "
10/01/2005 - "The median level of anillin mRNA expression was higher in tumors than normal tissues (median fold increase 2.58; 95% confidence intervals, 2.19-5.68, P < 0.0001) except in the central nervous system where anillin mRNA levels were lower in tumors. "
10/01/2005 - "The septin-binding protein anillin is overexpressed in diverse human tumors."
12/01/2015 - "Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma."
01/01/2009 - "NBL1 and anillin are promising markers for pancreatic carcinoma molecular diagnostics."
01/01/2009 - "NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma."
|3.||Ganglion Cysts (Ganglion)
|4.||Stomach Neoplasms (Stomach Cancer)
|5.||Schizophrenia (Dementia Praecox)
07/01/2010 - "We measured transcript levels of CDC42, CDC42EP3, CDC42EP4; their interacting proteins (septins [SEPT2, 3, 5, 6, 7, 8, and 11], anillin), and other spine-specific proteins (spinophilin, PSD-95, and synaptopodin) in the DLPFC from 31 subjects with schizophrenia and matched normal comparison subjects. "
|1.||Carrier Proteins (Binding Protein)
|2.||Proteins (Proteins, Gene)
|5.||Messenger RNA (mRNA)